Cours Satsuma Pharmaceuticals, Inc.
Actions
STSA
US80405P1075
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,26 % | 103 Md | |
+1,41 % | 95,71 Md | |
+0,70 % | 22,02 Md | |
-17,84 % | 20,9 Md | |
-10,35 % | 17,85 Md | |
-42,83 % | 16,21 Md | |
-17,63 % | 15,52 Md | |
+4,55 % | 13,86 Md | |
+32,11 % | 12,04 Md |